Do Women Make New Eggs? The Science of Female Fertility

Women are almost certainly born with all the eggs they will ever have, and the body does not appear to manufacture new ones after birth. This “fixed supply” view has dominated reproductive biology since 1951 and, despite a fierce challenge in the mid-2000s, remains the mainstream scientific position. The story is more nuanced than that single sentence, though, because the eggs a woman carries are not static objects sitting in storage. They age, they interact with a changing ovarian environment, and they have surprisingly robust self-repair systems that influence fertility throughout life.

How the Fixed-Supply Idea Became Dogma

In 1951, a scientist named Solomon Zuckerman published a landmark review concluding that female mammals are born with a set number of egg cells and never produce more. That idea became the bedrock of reproductive biology for the next half-century.¹ Before or shortly after birth, a girl’s ovaries contain somewhere around one to two million immature egg cells, called primordial follicles. By puberty, the number has already dropped to roughly 300,000 to 400,000 through a natural process of cell death. From that point on, eggs are spent each menstrual cycle, and the pool gradually shrinks until menopause, when too few remain to sustain regular ovulation.

For decades, nobody seriously questioned this framework. It made intuitive sense: sperm are produced continuously from puberty onward, while eggs are a finite endowment. This asymmetry was thought to reflect a fundamental difference in how male and female reproductive cells develop. The adult mammalian ovary, according to this view, simply lacks the stem cells needed to generate new eggs.²

The Challenge That Shook the Field

In 2004, a paper published in Nature dropped a bombshell. Researchers reported evidence that adult mouse ovaries contained stem cells capable of producing new eggs, contradicting Zuckerman’s dogma directly.¹ In the years that followed, multiple labs claimed to have isolated what they called oogonial stem cells (OSCs) from both rodent and human ovaries. These cells showed markers associated with both germ cells and stem cells in culture, and when placed back into a rodent ovary, they appeared to form follicles that produced healthy offspring.³ Some researchers even reported that human OSCs could form structures resembling immature eggs when transplanted into mouse ovarian tissue.⁴

The implications, had they held up, would have been enormous. If adult ovaries could make fresh eggs, it would mean that the ticking biological clock was not as absolute as everyone assumed. It could have opened entirely new paths to treating infertility.

Why Most Scientists Remain Skeptical

The excitement was short-lived, at least for the broader scientific community. Repeated attempts by independent labs to confirm the existence of oogonial stem cells have largely failed. One of the more definitive blows came from the first single-cell analysis of the human ovarian cortex, which identified six main cell types but found no oogonial stem cells among them. What earlier researchers had identified as egg-producing stem cells appeared instead to be perivascular cells, a type of support cell found near blood vessels.⁵

Animal experiments have reinforced the skepticism. A mouse study using dual genetic-tracing technology tracked whether any new eggs appeared after birth, either under normal conditions or after chemically induced ovarian injury. Regardless of how long the researchers waited, no newly formed eggs were detected.⁶ The researchers concluded that new egg formation simply does not happen in living mice, and that this finding has implications for human biology as well.

The debate has not been formally “closed” in the way scientific debates rarely are, but the weight of evidence has shifted heavily toward the traditional view. Most reproductive biologists now work from the assumption that the eggs you are born with are the eggs you get.

What Happens to Those Eggs Over Time

If no new eggs are being made, then the eggs ovulated at age 38 are themselves 38 years old, having been in a state of suspended animation since before birth. That is a remarkably long time for any cell to remain viable, and it explains a lot about why fertility declines with age. The aging process affects eggs in multiple ways: chromosomal abnormalities become more common, mitochondria (the energy-producing structures inside cells) become less efficient, and DNA accumulates damage.⁷

But eggs are not passive victims of time. Research has shown that resting oocytes possess surprisingly powerful DNA repair mechanisms. When exposed to radiation-induced damage, eggs can activate repair pathways that fix double-strand DNA breaks through a process called homologous recombination. This repair is effective enough to support fertility and maintain genetic health in offspring.⁸ The problem is that one of the key proteins driving this repair, called ATM, becomes less effective as eggs age. When ATM function is reduced experimentally, oocytes accumulate far more DNA damage after exposure to harmful chemicals.⁹ So eggs have a built-in quality-control system, but that system itself degrades over time.

The Ovary Ages Too, Not Just the Eggs

It would be a mistake to think of fertility decline as purely a problem of old eggs. The tissue surrounding the eggs, the ovarian microenvironment, also changes in ways that affect egg development. As ovaries age, they become physically stiffer. Collagen accumulates and another structural molecule called hyaluronan decreases, and this stiffening has been found in both mouse and human ovaries.¹⁰

This matters because follicles are extremely sensitive to the mechanical properties of their surroundings. Mouse experiments comparing follicle growth in soft versus stiff environments showed dramatic differences: in a soft environment, nearly all follicles survived and grew normally over 12 days, while in a stiffer environment mimicking an older ovary, fewer than 7% of follicles from one mouse strain and 30% from another remained viable. In an extremely stiff environment, none survived.¹¹ The upshot is that even if your eggs are in relatively good condition, the aging ovary itself can impair their ability to develop properly.

How Quickly the Reserve Runs Down

The rate at which primordial follicles “wake up” and enter the development pipeline is a key factor in how long a woman remains fertile. Normally, only a small batch of dormant follicles activate each cycle. The rest remain in reserve, their activation kept in check by molecular signals. Research has found that appropriately slowing this activation rate can delay ovarian aging and preserve fertility for longer.¹²

Certain stresses can accelerate follicle depletion. Animal studies have shown that oxygen deprivation around the time of birth can cause a premature shift of dormant follicles into active ones, reducing the overall reserve.¹³ Environmental chemicals and certain medications are also known to accelerate ovarian reserve depletion. Chemotherapy and radiation therapy are among the most potent offenders, but exposure to various industrial chemicals and pesticides can also damage the egg supply.¹⁴ Because new eggs are not being made, any damage to the reserve is permanent.

Measuring What You Have Left

Doctors use two main tools to estimate a woman’s remaining ovarian reserve. The first is anti-Müllerian hormone (AMH), a protein produced by the small follicles in the ovary; its blood level roughly reflects how many follicles are available. The second is an antral follicle count (AFC), which uses ultrasound to count the small, fluid-filled follicles visible on the ovaries. AMH levels help clinicians tailor fertility treatment doses and can flag a risk of poor response, though they have limited value in predicting whether a pregnancy will actually happen.¹⁵

Interestingly, these two tests do not always agree. A study comparing AMH and AFC found that ultrasound-based follicle counts identified diminished ovarian reserve about two years earlier than AMH blood levels did, detecting it at age 38 versus age 40. The two markers showed only poor agreement in classifying individual women, which means relying on just one can give an incomplete picture.¹⁶ Neither test tells you about egg quality, only quantity. A woman with a healthy AMH level can still have age-related declines in the genetic integrity of her remaining eggs.

Egg Freezing and What the Numbers Look Like

Since women cannot make new eggs, preserving existing ones has become an increasingly popular strategy, especially for those who want to delay pregnancy. Egg freezing, technically called oocyte cryopreservation, involves stimulating the ovaries to mature multiple eggs in one cycle, retrieving them, and flash-freezing them for later use. A cohort study found that the live birth rate per embryo transfer using previously frozen eggs was about 35%, with younger women (under 38 at the time of freezing) doing better at 38% and older women achieving about 29%.¹⁷

The number of eggs frozen matters a great deal. In the same study, women who thawed more than 15 eggs had a pregnancy rate of about 64% per patient, compared with 27% for those who thawed fewer than 15. That gap underscores the reality that not every frozen egg will survive thawing, fertilize successfully, and develop into a viable embryo. Age at the time of freezing is the other major variable, because it determines the baseline quality of the eggs being preserved.

For women facing cancer treatment or other medical therapies that threaten fertility, ovarian tissue cryopreservation and transplantation offers another option. This involves surgically removing strips of ovarian tissue before treatment and reimplanting them afterward. Clinical evidence confirms that this approach can restore both fertility, including the potential for natural conception, and the ovary’s hormone-producing function.¹⁸ Researchers are also experimenting with hydrogel scaffolds and bioactive supplements to improve how well transplanted tissue survives and functions.¹⁹

Experimental Approaches to Boosting a Depleted Reserve

For women who already have a diminished ovarian reserve and want to conceive, some clinics offer an experimental treatment: injecting platelet-rich plasma (PRP) directly into the ovaries. PRP is made from the patient’s own blood and contains concentrated growth factors. A study of 510 women with poor ovarian response found that after PRP injection, several ovarian markers improved, and the group achieved a pregnancy rate of about 21% and a live birth rate of roughly 13%.²⁰

However, the excitement around PRP should be tempered. A systematic review and meta-analysis pooling 19 studies and nearly 1,800 women found that while before-and-after comparisons within the same patient looked encouraging, the controlled comparisons, including randomized trials, did not consistently show improvements in mature egg yield compared with control groups. The pooled live birth rate across single-arm analyses was about 11%.²¹ PRP is not generating new eggs. The thinking is that it may improve the ovarian environment enough to help existing dormant follicles develop more successfully, but the evidence is still thin.

Could Lab-Grown Eggs Change Everything?

The most radical potential workaround for a fixed egg supply is in vitro gametogenesis, or IVG: making functional eggs from stem cells in a laboratory dish. This has already been accomplished in mice. Researchers have taken pluripotent stem cells, coaxed them through the stages of egg cell development, and produced eggs that, when fertilized, yielded live mouse pups.²² The work has progressed through refined multi-step protocols that allow complete egg development outside the body.

Human applications remain distant. The process is technically demanding, success rates even in mice are low, and there are serious safety and ethical questions to resolve before anyone would attempt to use lab-grown human eggs clinically. But IVG represents a genuine paradigm shift in how researchers think about the problem. Instead of trying to find stem cells hiding in adult ovaries or trying to coax existing follicles to behave differently, it sidesteps the ovary entirely.²³

Ovarian Aging Affects More Than Fertility

One aspect of the fixed-egg-supply story that gets far less public attention is what ovarian aging means for the rest of the body. The ovaries are not just egg warehouses; they are endocrine organs producing estrogen, progesterone, and other hormones that influence virtually every organ system. Ovarian aging has been described as a critical driver of systemic aging in female bodies.²⁴ As egg supply dwindles and hormone production drops, the effects ripple outward. Current evidence links ovarian aging to cognitive decline, bone loss, and cardiovascular disease, and because sex hormone receptors are found throughout the body, the list of affected systems is likely broader still.²⁵

This framing reframes menopause itself: it is not merely the end of reproductive capacity but the loss of a hormonal engine that was supporting bone density, cardiovascular health, brain function, and more. Understanding that the ovary’s egg supply and its endocrine function are intertwined helps explain why researchers are interested in slowing ovarian aging for reasons well beyond fertility.

What Eggs Pass Down Beyond DNA

Because the eggs a woman carries are formed during her own fetal development, they are exposed to whatever her mother experienced during pregnancy, and those environmental exposures can leave marks. Epigenetic changes, modifications that affect how genes are read without altering the DNA sequence itself, can accumulate in germ cells and may be passed to the next generation.²⁶

Animal studies have demonstrated this in stark terms. When pregnant rats were exposed to the pesticide methoxychlor during the period of fetal gonadal development, the effects did not stop with their daughters. Increased rates of kidney disease, ovarian disease, and obesity showed up in great-grandchildren, and the transmission tracked primarily through the female line.²⁷ The implication is striking: an environmental exposure affecting a pregnant woman may alter the eggs inside her female fetus, and those altered eggs may carry changes forward for multiple generations without any new exposure. The fixed egg supply is not just a constraint on individual fertility. It also acts as a multigenerational recording medium for environmental insults.

Why Eggs Accumulate Fewer Mutations Than You Might Expect

Given that human eggs sit dormant for decades, you might assume they accumulate enormous numbers of genetic mutations. In fact, the opposite is true relative to sperm. Sperm-producing cells divide continuously after puberty, and each division is an opportunity for a copying error. By contrast, eggs undergo their cell divisions early in fetal life and then stop, entering a long resting phase. Research estimating germline mutation rates has found that post-pubertal sperm production introduces roughly two to four new mutations per year, while the total maternal contribution across all the cell divisions involved in egg formation is in the range of 10 to 14 mutations total, not per year.²⁸ So while each individual cell division during egg formation is actually more error-prone than a spermatogenic division, the sheer lack of ongoing divisions means eggs accumulate far fewer total mutations. The fixed supply, in this sense, is a feature rather than a bug: by not dividing, eggs avoid the copying errors that come with constant replication.